Efficacy of omalizumab in patients with concomitant allergic asthma and atopic dermatitis: a pilot study Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Long-term trends of asthma, allergic rhinitis and atopic eczema in young Finnish men: a retrospective analysis, 1926–2017 Source: Eur Respir J, 56 (6) 1902144; 10.1183/13993003.02144-2019 Year: 2020
Impact of subcutaneous allergoid AIT on patients with allergic rhinitis and/or asthma: A retrospective real-life, long-term cohort analysis Source: Virtual Congress 2020 – Management of allergy, asthma and COPD Year: 2020
Real-life effectiveness of omalizumab in patients with severe persistent allergic asthma: the PERSIST study Source: Annual Congress 2009 - Towards improving asthma control Year: 2009
Detection of genetic alterations in nasal aspirates from COPD, asthmatic and allergic rhinitis patients: preliminary results Source: Eur Respir J 2005; 26: Suppl. 49, 483s Year: 2005
The evaluations of allergic rhinitis symptoms in patients with asthma and allergic rhinitis with the addiing of montelukast in asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004
Long-term effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma: Real-life data from 3 UK centres Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE Year: 2012
Real-life effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma: Pooled data from 3 UK centres Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011
Evaluation of asthma patients using the control of allergic rhinitis and asthma test (CARAT) Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012
Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study Source: Eur Respir J 2003; 21: 116-122 Year: 2003
Real-life effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma: Pooled data from 4 UK centres Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE Year: 2012
Airway inflammation in non-eosinophilic atopic asthma: comparisons with eosinophilic atopic asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005
Asthma, atopy and lung abnormalities 20 years after infantile lower respiratory infection in atopic and non-atopic children: results from a prospective follow-up study Source: Eur Respir J 2003; 22: Suppl. 45, 497s Year: 2003
Cost-effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma: adaptation of INNOVATE and ETOPA data to the Netherlands Source: Annual Congress 2007 - Cost-effectiveness in diagnosis, therapy and care Year: 2007
Real-life effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma at a single UK hospital Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
A population-based clinical study of allergic and non-allergic asthma Source: Annual Congress 2008 - Markers and triggers of asthma Year: 2008
Combined childhood flexural eczema and rhinitis predicts atopic asthma but not non-atopic asthma Source: Annual Congress 2010 - New insights in the epidemiology of asthma Year: 2010
Controlled asthma in atopic and non atopic patients: Is needed a different approach? Source: Annual Congress 2011 - Asthma: improving diagnosis and management for reaching better control Year: 2011
Rhinitis prevalence and its relationship with asthma, atopic dermatitis and allergic sensitization in school children Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008
Gender differences in asthma: prevalence, diagnosis, and incidence of atopic and non atopic asthma Source: Annual Congress 2008 - Epidemiology of asthma and allergy Year: 2008